Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04535583 · ClinicalTrials.gov registry record

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder

A clinical trial of Opioid Use Disorder, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
65
Enrollment target
1
Study location

NCT04535583 is a study of Opioid Use Disorder that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 65 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04535583, a study of Opioid Use Disorder, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
65 participants
Enrollment target
1
Study location

Study Summary

The main objective of the study is to evaluate the feasibility of utilizing digital health technology with opioid use disorder (OUD) patients as measured by a 12-week period of continuous assessment using smartphone surveys and digital sensing. In addition, we will examine the utility of 3 types of digital data (Ecological Momentary Assessment (EMA); Digital sensing; and social media data) in predicting OUD treatment retention and buprenorphine medication adherence.

Conditions Studied

Study Locations (1)

California

  • Kaiser Permanente Northern California, Division of Research - Oakland

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2020-07-23
Est. Completion 2021-09-21

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT04535583

The ClinicalTrials.gov registry entry for NCT04535583 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT04535583 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04535583 about?

NCT04535583 is a clinical study titled "Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder". The main objective of the study is to evaluate the feasibility of utilizing digital health technology with opioid use disorder (OUD) patients as measured by a 12-week period of continuous assessment using smartphone surveys and digital sensing. In addition, we will examine the utility of 3 types of ...

What is the current status of trial NCT04535583?

This trial is currently completed. The enrollment target is 65 participants. The study started on 2020-07-23. Estimated completion is 2021-09-21.

What conditions does trial NCT04535583 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

Who is sponsoring clinical trial NCT04535583?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04535583 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.